U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07421102) titled 'Pilot of Mailing Buprenorphine' on Feb. 12.
Brief Summary: This pilot study evaluates the feasibility, acceptability, and preliminary effectiveness of mailing buprenorphine to individuals with opioid use disorder (OUD) following medical hospitalization. The intervention aims to improve retention in treatment by overcoming barriers such as transportation and pharmacy access.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Opioid Use Disorder
Intervention:
OTHER: strategy of mailing buprenorphine
This study examines the feasibility and preliminary effectiveness of mailing buprenorphine to overcome barriers su...